Tue 2/19/2019 11:46 ET
DJIA25881.782.590.01%TELCO164.010.210.13%GOLD1340.3518.231.36%Shanghai2755.6535.001.27%
S&P 5002778.623.060.11%BANKS439.252.460.56%OIL56.300.320.57%BITCOIN3980.7669.271.74%
NASDAQ7486.8614.230.19%PHARM572.730.800.14%US/EU1.130.000.00%Futures2775.381.670.06%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Protalix BioTherapeutics - PLX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  
From: ZackMorris (Rep: 0)Date: 01/02/2018 08:27
Forum: Protalix BioTherapeutics - Msg #340Thread #673978230 (Rec: 0)
$PLX Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis



Zack Attack!



NOTE: This message was originally posted on 2018-01-02 07:03:28 by the ZackMorris.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser ZackMorris: Reward | Watch | IgnorePLX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.